IP Library Granted Patent US 11,213,569
Granted Patent B2
US 11,213,569 · App. 15/757,186 · Granted Jan 4, 2022

Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations

Inventor: Saher Hamed (Nazareth Illit, IL)
Assignee: Remedor Biomed Ltd.
A61K38/1816A61K8/042A61K8/64A61K9/0014A61K9/06A61K38/39A61K47/10A61K47/14A61K47/18A61K47/32A61P17/02A61Q19/00A61K2300/00C07K14/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,213,569
App. No.
15/757,186
Granted
Jan 4, 2022
Kind
B2
Abstract

Topical formulations containing erythropoietin (EPO), and also preferably fibronectin (FN), especially gel formulations, are used to accelerate wound healing, e.g., from a burn, compared to the healing process without such a formulation being applied. Methods of preparing the formulations are also provided.

Claims (12)

1. A composition consisting of:

5% w/w erythropoietin;

30% w/w fibronectin;

5% w/w glycerol;

1% w/w Carbomer 940;

2% w/w benzyl alcohol;

0.9% w/w triethanolamine;

0.2% w/w methylparaben;

0.05% w/w propylparaben; and

water to 100% w/w;

wherein the composition is a gel.

2. A method of treating a wound comprising topically applying a therapeutically effective amount of the formulation of claim 1 to a wound in order to treat the wound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2018
From: HAMED, SAHER
To: REMEDOR BIOMED LTD.
Reel/Frame 045491/0062 →
Continuity (2)
Provisional Application 62214618 · Sep 4, 2015
Related Publication 20180243373A1 · Aug 30, 2018
Cited By (2)
US 12,343,238 US 12,558,458